benzoxazoles has been researched along with Bronchiectasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chalmers, JD; Fernandez, C; Mange, KC; Rubino, CM; Teper, A; Usansky, H; Zou, J | 1 |
Blasi, F; Chalmers, JD; Daley, CL; Fernandez, C; Haworth, CS; Loebinger, MR; Mange, KC; Metersky, ML; O'Donnell, AE; Sibila, O; Sullivan, EJ; Zou, J | 1 |
2 trial(s) available for benzoxazoles and Bronchiectasis
Article | Year |
---|---|
Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis.
Topics: Adult; Benzoxazoles; Bronchiectasis; Cathepsin G; Cystic Fibrosis; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Fibrosis; Humans; Leukocyte Elastase; Myeloblastin; Oxazepines; Serine Proteases | 2022 |
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
Topics: Adult; Aged; Aged, 80 and over; Benzoxazoles; Bronchiectasis; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukocyte Elastase; Male; Middle Aged; Oxazepines; Serine Proteases; Sputum | 2020 |